| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 278, Issue 21, 19023-19031, May 23, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
¶
From the
Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599,
¶ Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599
Previous work indicates that RhoA phosphorylation on Ser188 by cAMP or cGMP-dependent kinases inhibits its activity. However, these studies lacked the possibility to directly study phosphorylated RhoA activity in vivo. Therefore, we created RhoA proteins containing phosphomimetic residues in place of the cAMP/cGMP-dependent kinase phosphorylation site. RhoA phosphorylation or phosphomimetic substitution did not affect Rho guanine nucleotide exchange factor, GTPase activating protein, or geranylgeranyl transferase activity in vitro but promoted binding to the Rho guanine-dissociation inhibitor as measured by exchange factor competition assays. The in vitro similarities between RhoA phosphomimetic proteins and phosphorylated RhoA allowed us to study function of phosphorylated RhoA in vivo. RhoA phosphomimetic proteins display depressed GTP loading when transiently expressed in NIH 3T3 cells. Stable-expressing RhoA and RhoA(S188A) clones spread significantly slower than mock-transfected or RhoA(S188E) clones. RhoA(S188A) clones were protected from the morphological effects of a cAMP agonist, whereas phosphomimetic clones exhibit stress fiber disassembly similar to control cells. Together, these data provide in vivo evidence that addition of a charged group to Ser188 upon phosphorylation negatively regulates RhoA activity and indicates that this occurs through enhanced Rho guanine-dissociation inhibitor interaction rather than direct perturbation of guanine nucleotide exchange factor, GTPase activating protein, or geranylgeranyl transferase activity.
Received for publication, December 20, 2002 , and in revised form, March 20, 2003.
To whom correspondence should be addressed: Lineberger Comprehensive Cancer Center, CB 7295, University of North Carolina, Chapel Hill, NC 27599. Tel.: 919-966-1904; Fax: 919-966-1856; E-mail: hawkeye{at}med.unc.edu.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. M. Fontainhas and E. Townes-Anderson RhoA and Its Role in Synaptic Structural Plasticity of Isolated Salamander Photoreceptors Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4177 - 4187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. Moore, J. P. Correia, K. Lai Wing Sun, M. Pool, A. E. Fournier, and T. E. Kennedy Rho inhibition recruits DCC to the neuronal plasma membrane and enhances axon chemoattraction to netrin 1 Development, September 1, 2008; 135(17): 2855 - 2864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats Cardiovasc Res, July 15, 2008; 79(2): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Wojciak-Stothard New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling Postgrad. Med. J., July 1, 2008; 84(993): 348 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Eguchi Triple Twist Theory of Rho Inhibition by the Angiotensin II Type 2 Receptor Circ. Res., May 23, 2008; 102(10): 1143 - 1145. [Full Text] [PDF]
|
|
|
|
 |
|
 S. E Fiedler, M. Bajpai, and D. W Carr Identification and Characterization of RHOA-Interacting Proteins in Bovine Spermatozoa Biol Reprod, January 1, 2008; 78(1): 184 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Kass, E. Takimoto, T. Nagayama, and H. C. Champion Phosphodiesterase regulation of nitric oxide signaling Cardiovasc Res, July 15, 2007; 75(2): 303 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gorovoy, R. Neamu, J. Niu, S. Vogel, D. Predescu, J. Miyoshi, Y. Takai, V. Kini, D. Mehta, A. B. Malik, et al. RhoGDI-1 Modulation of the Activity of Monomeric RhoGTPase RhoA Regulates Endothelial Barrier Function in Mouse Lungs Circ. Res., July 6, 2007; 101(1): 50 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hirakawa, Y. Karashima, M. Watanabe, C. Kimura, Y. Ito, and M. Oike Protein Kinase A Inhibits Lysophosphatidic Acid-Induced Migration of Airway Smooth Muscle Cells J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1102 - 1108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Luykenaar and D. G. Welsh Activators of the PKA and PKG pathways attenuate RhoA-mediated suppression of the KDR current in cerebral arteries Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2654 - H2663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tura, S. Grisanti, K. Petermeier, and S. Henke-Fahle The Rho-Kinase Inhibitor H-1152P Suppresses the Wound-Healing Activities of Human Tenon's Capsule Fibroblasts In Vitro Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2152 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D'hondt, S. P. Srinivas, J. Vereecke, and B. Himpens Adenosine Opposes Thrombin-Induced Inhibition of Intercellular Calcium Wave in Corneal Endothelial Cells Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1518 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Wojciak-Stothard, B. Torondel, L. Y. F. Tsang, I. Fleming, B. Fisslthaler, J. M. Leiper, and P. Vallance The ADMA/DDAH pathway is a critical regulator of endothelial cell motility J. Cell Sci., March 15, 2007; 120(6): 929 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Z. Alabed, M. Pool, S. O. Tone, and A. E. Fournier Identification of CRMP4 as a Convergent Regulator of Axon Outgrowth Inhibition J. Neurosci., February 14, 2007; 27(7): 1702 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Fessler, P. G. Arndt, I. Just, J. A. Nick, K. C. Malcolm, and G. Scott Worthen Dual role for RhoA in suppression and induction of cytokines in the human neutrophil Blood, February 1, 2007; 109(3): 1248 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Eun, B. P. O'Connor, A. W. Wong, H. W. van Deventer, D. J. Taxman, W. Reed, P. Li, J. S. Blum, K. P. McKinnon, and J. P.-Y. Ting Cutting Edge: Rho Activation and Actin Polarization Are Dependent on Plexin-A1 in Dendritic Cells J. Immunol., October 1, 2006; 177(7): 4271 - 4275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Kalamidas, M. P. Kuehnel, P. Peyron, V. Rybin, S. Rauch, O. B. Kotoulas, M. Houslay, B. A. Hemmings, M. G. Gutierrez, E. Anes, et al. cAMP synthesis and degradation by phagosomes regulate actin assembly and fusion events: consequences for mycobacteria. J. Cell Sci., September 1, 2006; 119(Pt 17): 3686 - 3694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Severinova and K. Severinov Localization of the Escherichia coli RNA Polymerase {beta}' Subunit Residue Phosphorylated by Bacteriophage T7 Kinase Gp0.7. J. Bacteriol., May 1, 2006; 188(10): 3470 - 3476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Dodge-Kafka, L. Langeberg, and J. D. Scott Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of A-Kinase Anchoring Proteins Circ. Res., April 28, 2006; 98(8): 993 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Hofmann, R. Feil, T. Kleppisch, and J. Schlossmann Function of cGMP-Dependent Protein Kinases as Revealed by Gene Deletion Physiol Rev, January 1, 2006; 86(1): 1 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Howe, L. C. Baldor, and B. P. Hogan Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration PNAS, October 4, 2005; 102(40): 14320 - 14325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. M. Goeckeler and R. B. Wysolmerski Myosin Phosphatase and Cofilin Mediate cAMP/cAMP-dependent Protein Kinase-induced Decline in Endothelial Cell Isometric Tension and Myosin II Regulatory Light Chain Phosphorylation J. Biol. Chem., September 23, 2005; 280(38): 33083 - 33095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-L. Lin, R.-H. Chen, Y.-M. Chen, W.-C. Chiang, C.-F. Lai, K.-D. Wu, and T.-J. Tsai Pentoxifylline Attenuates Tubulointerstitial Fibrosis by Blocking Smad3/4-Activated Transcription and Profibrogenic Effects of Connective Tissue Growth Factor J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2702 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Cardone, A. Bagorda, A. Bellizzi, G. Busco, L. Guerra, A. Paradiso, V. Casavola, M. Zaccolo, and S. J. Reshkin Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines Mol. Biol. Cell, July 1, 2005; 16(7): 3117 - 3127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rolli-Derkinderen, V. Sauzeau, L. Boyer, E. Lemichez, C. Baron, D. Henrion, G. Loirand, and P. Pacaud Phosphorylation of Serine 188 Protects RhoA from Ubiquitin/Proteasome-Mediated Degradation in Vascular Smooth Muscle Cells Circ. Res., June 10, 2005; 96(11): 1152 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Andresen, K. Shome, E. K. Jackson, and G. G. Romero AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity Am J Physiol Renal Physiol, April 1, 2005; 288(4): F763 - F770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dutt, A. B. Jaffe, K. D. Merdek, A. Hall, and D. Toksoz G{alpha}z Inhibits Serum Response Factor-Dependent Transcription by Inhibiting Rho Signaling Mol. Pharmacol., December 1, 2004; 66(6): 1508 - 1516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Waschke, D. Drenckhahn, R. H. Adamson, H. Barth, and F. E. Curry cAMP protects endothelial barrier functions by preventing Rac-1 inhibition Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2427 - H2433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Brown and C. E. Turner Paxillin: Adapting to Change Physiol Rev, October 1, 2004; 84(4): 1315 - 1339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Hartshorne, M. Ito, and F. Erdodi Role of Protein Phosphatase Type 1 in Contractile Functions: Myosin Phosphatase J. Biol. Chem., September 3, 2004; 279(36): 37211 - 37214. [Full Text] [PDF]
|
|
|
|
|
|
L. Ling and P. E. Lobie RhoA/ROCK Activation by Growth Hormone Abrogates p300/Histone Deacetylase 6 Repression of Stat5-mediated Transcription J. Biol. Chem., July 30, 2004; 279(31): 32737 - 32750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Fleming, M. C. Frame, and M. D. Houslay PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration J. Cell Sci., May 1, 2004; 117(11): 2377 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wennerberg and C. J. Der Rho-family GTPases: it's not only Rac and Rho (and I like it) J. Cell Sci., March 15, 2004; 117(8): 1301 - 1312. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
